In CLL, Lck promotes B-cell receptor (BCR) signaling, contributing to cell survival and glucocorticoid resistance and inhibiting Lck-inducing apoptosis in CLL cell lines. Here, LCK is linked to B-cell chronic lymphocytic leukemia.